MRI Diagnostics Maker T2 Biosystems Boosts IPO Cap To $78.2 Million

Massachusetts-based T2 Biosystems raised its hopes for its upcoming initial public offering, raising its maximum aggregate take to $78.2 million if shares sell at $17 apiece.

The company had previously set its max raise at $69 million before releasing more detail about its IPO. In a new SEC filing T2 said it plans to sell 4 million shares at $15-$17 apiece.

At the $16 mid-point of the range, the company would raise $64 million for its MRI-based diagnostic systems.

Help employers find you! Check out all the jobs and post your resume.